SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech for less than cash value -- Ignore unavailable to you. Want to Upgrade?


To: nigel bates who wrote (134)10/5/2002 8:05:21 PM
From: tom pope  Read Replies (1) | Respond to of 684
 
Just missing the cut, trading around cash - and presumably well off the list next time they report - are CRXL, AMEV, IMGN and LSBC.


Doubtless because their prices have appreciated so mightily?



To: nigel bates who wrote (134)10/8/2002 8:53:48 AM
From: rkrw  Read Replies (2) | Respond to of 684
 
Here's one for you: far fewer biotechs trading in double digits, than biotechs selling below cash.

Biotech's trading >$10:

adlr, alxn, amln, bgen, celg, ceph, cvtx, enzn, genz, gild, hgsi, icos, idph, itmn, medi, nbix, npsp, osip, regn, sang, scio, telk, tktx, tnox, trms, uthr, vrtx.